| scholarly article | Q13442814 |
| P50 | author | Yves Agid | Q3573439 |
| Maria Graziella De Montis | Q59677182 | ||
| P2093 | author name string | A. Lowenthal | |
| K. Beaumont | |||
| K. G. Lloyd | |||
| F. Javoy-Agid | |||
| J. Constandinidis | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Pharmacological Reviews | Q2085079 | ||
| Fifth Gaddum Memorial Lecture, University of Bristol, September 1974, The glycine synaptic receptor in the mammalian central nervous system | Q34021934 | ||
| Strychnine binding associated with glycine receptors of the central nervous system | Q34737634 | ||
| Caudate stimulation and substantia nigra activity in the rat | Q36799727 | ||
| Neurobiology and pharmacology of Huntington's disease | Q37339607 | ||
| Interaction of benzodiazepines with central nervous glycine receptors: possible mechanism of action | Q37447288 | ||
| Synaptic mechanisms in the substantia nigra | Q39099350 | ||
| Benzodiazepine activity: is interaction with the glycine receptor, as evidenced by displacement of strychnine binding, a useful criterion? | Q39160997 | ||
| GABAergic and glycinergic mechanisms within the substantia nigra: Pharmacological specificity of dopamine-independent contralateral turning behavior and interactions with other neurotransmitters | Q39259456 | ||
| Is glycine an inhibitory synaptic transmitter in the substantia nigra? | Q39274777 | ||
| Central glycine-receptors | Q39741222 | ||
| Inhibition of dopamine release in the cat caudate nucleus by nigral application of glycine | Q41037908 | ||
| Specific stimulating effect of glycine on 3H-dopamine efflux from substantia nigra slices of the rat | Q41445580 | ||
| Distribution of high affinity sodium-independent [3H]gamma-aminobutyric acid [3H]GABA binding in the human brain: alterations in Parkinson's disease | Q42444591 | ||
| Is the mesocortical dopaminergic system involved in Parkinson disease? | Q42445938 | ||
| Pharmacology of cortical inhibition | Q47715638 | ||
| GABA receptor binding in the parkinsonian brain | Q48181663 | ||
| High affinity uptake systems for glycine, glutamic and aspaspartic acids in synaptosomes of rat central nervous tissues | Q48741011 | ||
| Studies of the uptake of3H-GABA and [3H]glycine in slices and homogenates of rat brain and spinal cord by electron microscopic autoradiography | Q48754157 | ||
| Effects of strychnine, bicuculline and picrotoxin on labyrinthine-evoked inhibition in neck motoneurons of the cat. | Q48772989 | ||
| The specificity of strychnine as a glycine antagonist in the mammalian spinal cord | Q48818882 | ||
| A comparison of the concentration of glycine, a transmitter suspect, in different areas of the brain and spinal cord in seven different vertebrates | Q49050824 | ||
| Glycine uptake in rat central nervous system slices and homogenates: evidence for different uptake systems in spinal cord and cerebral cortex | Q51120514 | ||
| A pharmacological study of the depression of spinal neurones by glycine and related amino acids | Q51193298 | ||
| Symmetric bilateral changes in dopamine release from the caudate nuclei of the cat induced by unilateral nigral application of glycine and gaba-related compounds | Q52701265 | ||
| Studies on convulsants in the isolated frog spinal cord. I. Antagonism of amino acid responses | Q54628419 | ||
| Distribution of Catecholamines in the Ventral Mesencephalon of Human Brain, with Special Reference to Parkinson's Disease | Q64785695 | ||
| Chemical Nature of Synaptic Transmission in Vertebrates | Q98839729 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biochemistry | Q7094 |
| substantia nigra | Q753278 | ||
| P304 | page(s) | 718-724 | |
| P577 | publication date | 1982-03-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Glycine receptors in the human substantia nigra as defined by [3H]strychnine binding | |
| Glycine Receptors in the Human Substantia Nigra as Defined by [3H]Strychnine Binding | |||
| P478 | volume | 38 |
| Q40091500 | Amino acid neurotransmitters and their pathways in the mammalian central nervous system |
| Q39464865 | Anatomy and pathology of the basal ganglia |
| Q43558018 | Attenuation of malonate toxicity in primary mesencephalic cultures using the GABA transport blocker, NO-711. |
| Q48250573 | Evidence for a possible glycinergic inhibitory neurotransmission in the midbrain and rostral pons of the rat studied by gephyrin |
| Q43794080 | Glycine receptor-mediated inhibition of dopamine and non-dopamine neurons of the rat ventral tegmental area in vitro |
| Q42511378 | Glycine receptors in the striatum, globus pallidus, and substantia nigra of the human brain: an immunohistochemical study |
| Q30886039 | Localization of glycine receptors in the human forebrain, brainstem, and cervical spinal cord: an immunohistochemical review |
| Q38887346 | Molecular changes in the postmortem parkinsonian brain |
| Q40096918 | Neurochemical Anatomy of Movement Disorders |
| Q71614053 | Pilot study of threonine supplementation in human spasticity |
| Q44295418 | Regional distribution of the cells expressing glycine receptor β subunit mRNA in the rat brain |
| Q49049351 | The effects of strychnine on the regulation of voltage-dependent calcium channels by dihydropyridines in brain and heart |
| Q43089203 | The localization of inhibitory neurotransmitter receptors on dopaminergic neurons of the human substantia nigra |
Search more.